Canada Sees Face-Off Over Higher-Strength Adalimumab

Jamp And Alvotech Go Head-To-Head With Celltrion On 100mg/ml Biosimilar Humira

Hot on the heels of rival Celltrion, Jamp and partner Alvotech have now launched their own higher-strength adalimumab biosimilar in Canada, setting up a showdown between their Simlandi version and Celltrion’s Yuflyma.

Canada Flag Boxing Gloves Fight
Simlandi and Yuflyma are going head-to-head in Canada • Source: EyeEm / Alamy Stock Photo

Just days after Celltrion announced the Canadian launch of its Yuflyma (adalimumab) higher-strength 100mg/ml biosimilar rival to Humira, partners Jamp and Alvotech have followed suit with their Simlandi version.

The launch sets up a head-to-head battle between the two high-concentration Humira biosimilars in Canada, as Alvotech also prepares to...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Products

More from Generics Bulletin